Zubair Ahmed, MD


Characterizing Real-World Outcomes With Eptinezumab in Migraine: Zubair Ahmed, MD

The neurologist from Cleveland Clinic discussed the importance of studying real-world outcomes in patients with migraine using CGRPs such as eptinezumab.

Hesham Abboud, MD, PhD


The Future of Multiple Sclerosis Treatment

Ahmed Obeidat, MD, PhD; Benjamin Greenberg, MD; and Hesham Abboud, MD, share their hopes about the evolution of future mutiple sclerosis care and express their gratitude for the next generation of neurologists.

Matthew Kiernan, MBBS, PhD, DSc, FRACP, FAHMS


The Paradigm Shift in Therapeutic Intervention for ALS: Matthew Kiernan, MBBS, PhD, DSc, FRACP, FAHMS

The Bushell Chair of Neurology at the University of Sydney offered his perspective on phase 2 data of CNM-Au8 in amyotrophic lateral sclerosis and spoke to the advances that the field has made in recent years. [WATCH TIME: 3 minutes]

Alberto Ramos, MD, MSPH, FAASM


Understanding Brain Differences in MRI Markers, Sleep-Disordered Breathing of Latino Individuals: Alberto Ramos, MD, MSPH, FAASM

The director of the Sleep Disorders program at the University of Miami discussed his research regarding the association of sleep disordered breathing and total brain volumes in Latino individuals. [WATCH TIME: 3 minutes]

Dayna Johnson, PhD, MPH, MSW, MS


Efforts to Overcome Sleep Issues in Underserved Communities: Dayna Johnson, PhD, MPH, MSW, MS

The sleep epidemiologist and assistant professor at the Rollins School of Public Health at Emory University discussed the multi-level effort needed to improve sleep issues seen in individuals most impacted by social determinants of health. [WATCH TIME: 3 minutes]

Jean Hubble, MD


Patient-Centric, Knowledge-Driven: Advanced Therapeutics in Movement and Related Disorders™ Congress

Clinicians must be armed with fact-based information on all treatment options especially newer medications and technologies—good clinical care must be both patient-centric and knowledge-driven.

Rich Sobieray


AUPN Leading Edge Episode 3: What Your CEO Wants From You

AUPN Leading Edge Episode 3 features Clifton Gooch, MD, and Rich Sobieray, who discuss expectations for chairs in the academic health systems. [LISTEN TIME: 37 minutes]



Managing Insomnia: Practical Advice for Community Physicians

Closing their discussion on insomnia, panelists share final thoughts and advice for community physicians.

Nicholas C. Ketchum, MD


Evolving Rehabilitation Strategies for Multiple Sclerosis

Ahmed Obeidat, MD, PhD; Francois Bethoux, MD; and Nicholas C. Ketchum, MD, discuss recent advancements and future directions in rehabilitation strategies for multiple sclerosis.

Tahseen Mozaffar, MD, FAAN


The Benefits of a New Therapy for Pompe Disease: Tahseen Mozaffar, MD, FAAN

On Rare Disease Day, the director of the Division of Neuromuscular Diseases at UC Irvine commented on the potential of AT845 for this patient population. [WATCH TIME: 3 minutes]

Bridget A. Bagert, MD, MPH


The Relationship Between Epstein-Barr Virus and Multiple Sclerosis

The paradigm-shifting evidence of the link between MS and EBV does not exist in isolation. In fact, the relationship has been suspected for more than 40 years, and evidence therein has been accumulating over the past 2 decades.

Amy Brin, MSN, MA, PCNS-BC


Adding Experience to the National Health Institute Council: Amy Brin, MSN, MA, PCNS-BC

The chief executive officer of the Child Neurology Foundation provided insight on her new position at the National Health Institute’s National Advisory Neurological Disorders and Stroke Council. [WATCH TIME: 4 minutes]

Alexander Scheer, MD


Clinical Perspective of Insomnia in Sleep Medicine

Alexander Scheer, MD, medical director at Scheer Medical Wellness, provided his medical perspective on insomnia in the clinical practice of sleep medicine.

Gabrielle Rushing, PhD


Preventing Epilepsy Through Antiseizure Medication in Tuberous Sclerosis Complex: Gabrielle Rushing, PhD

The director of research at the TSC Alliance spoke with us at the 2022 AES Conference about future research to be conducted on patients with TSC such as the PREVeNT trial. [WATCH TIME: 6 minutes]

Eric McDade, DO


Future Outlook for Alzheimer’s Disease

Drs Atri, Cohen, Sabbagh and McDade share their enthusiasm and optimism about the future outlook for Alzheimer’s disease.

David R. Zook, JD


Connecting ALS: How New Drug Coverage Decisions Are Made

In this episode of Connecting ALS, Dave R. Zook, JD, an advisor with expertise in federal regulatory policy, speaks to the process of making drug coverage decisions for newly approved therapies.

Ana Pereira, MD


Ana Pereira, MD: Repurposing Riluzole for Alzheimer Disease

The assistant professor of neurology and neuroscience at Mount Sinai Medical Center detailed the promise marked by the results of a recent pilot trial of riluzole in Alzheimer disease.

Jeffrey Wilken, PhD


CMSC Live: 2024 Annual Meeting Day 3

Host Jeffrey Wilken, PhD, chats with Marijean Buhse, PhD, RN, NP-C, MSCN; Amy Sullivan, PsyD, ABPP; and John DeLuca, PhD, ABPP, FACRM, FAPA, FAPS, FNAN, about the third day of the 2024 CMSC Annual Meeting in Nashville, Tennessee.

Manolo Bellotto, PhD


A New Approach to Protein Misfolding in Parkinson Disease

Previously, many promising treatments for PD have ultimately resulted in untenable adverse effects or in failure, but the evolving area of protein folding offers an opportunity to slow or reverse the neurodegenerative process.

Eric Zhou, PhD


Improvements to the Detection, Psychosocial Aspects of Narcolepsy in Adolescents: Eric Zhou, PhD

The assistant professor of pediatrics at Harvard Medical School provided perspective on the care needs of adolescents and young adults with narcolepsy, and the importance of early detection of lingering issues. [WATCH TIME: 3 minutes]

Burel Goodin, PhD


Proper Ways to Engage Underserved Populations in Pain Medicine: Burel Goodin, PhD

The professor of anesthesiology at Washington University in St. Louis provided perspective on the respect and approach that comes with conducting research in underserved or impoverished communities. [WATCH TIME: 4 minutes]

Alessio Travaglia, PhD


Incorporation of Biomarkers, Synaptic Plasticity, in Treatment Paradigm for Alzheimer Disease: Alessio Travaglia, PhD

The director at the Foundation for the National Institutes of Health discussed relevant biomarkers for Alzheimer disease and their role as novel therapeutics continue to emerge. [WATCH TIME: 5 minutes]

Rohini K. Coorg, MD


Less Invasive Epilepsy Surgery May Help Turn Candidates Into Consults

Recent advances in stereoelectroencephalography and laser ablation may help convert those who may be candidates for pediatric epilepsy surgery to those who proceed with a consultation.

Kenneth Ngo, MD


The Role of Music & Movement in Parkinson Disease Treatment

Kenneth Ngo, MD, medical director for the Brain Injury Program at Brooks Rehabilitation’s 3 inpatient hospitals, highlighted how cotreatment between music therapy and physical therapy can significantly improve the overall quality of life for patients with Parkinson disease.

Sait Ashina, MD


Tension-Type Headache, An Understudied and Undertreated Condition: Sait Ashina, MD, FAHS

The assistant professor of neurology at Harvard Medical School talked about the prevalence of tension-type headache and how recent advances shed light on its pathophysiological mechanisms, leading to potential new treatments for the condition. [WATCH TIME: 5 minutes]

Erika Fullwood Augustine, MD, MS


Evolving Landscape of Pediatric Neurology: Erika Fullwood Augustine, MD, MS

The associate chief science officer at Kennedy Krieger Institute shared thoughts on the state of pediatric neurology and the significance of being named winner of the Sydney Carter Award. [WATCH TIME: 3 minutes]

Deborah Miller, PhD


Discontinuing Disease-Modifying Therapies in Multiple Sclerosis: Deborah Miller, PhD

The staff member at the Mellen Center for Multiple Sclerosis discussed reasons why patients may stop treatment, as well as strategies for maintaining communication with the healthcare team in the event of discontinuation. [WATCH TIME: 5 minutes]

Matthew Shepard, MD


Exploring Potential Therapeutic Opportunities for GammaTile in Neurosurgery: Matthew Shepard, MD

The neurosurgeon at Allegheny Health Network discussed the current uses of GammaTile following tumor removal, and the research needed to unlock greater potential. [WATCH TIME: 3 minutes]

Farrah Mateen, MD, PhD


Creating Positive, Helpful Work Environments for Patients With NMOSD: Farrah Mateen, MD, PhD

The associate director of the Multiple Sclerosis & Neuromyelitis Optica Unit at Massachusetts General Hospital discussed the ways employers and clinicians can alleviate work hardships experienced by patients with NMOSD. [WATCH TIME: 3 minutes]

Katharina Eikermann-Haerter, MD


Future Research on Neuronal Microstructure Integrity in Migraine Using High-Gradient Diffusion MRI: Katharina Eikermann-Haerter, MD

The associate professor in the department of radiology at NYU Langone provided perspective on the unanswered questions regarding neuronal microstructure in migraine following her presentation at the 2024 AAN Annual Meeting. [WATCH TIME: 4 minutes]

© 2024 MJH Life Sciences

All rights reserved.